Nanexa AB (publ) announced a private placement of 10,000,000 shares at a price of SEK 1.72 per share for gross proceeds of SEK 17,200,000 on December 21, 2022. The transaction included participation from existing investor Novo Nordisk A/S.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 SEK | -2.73% | +25.59% | -13.01% |
May. 15 | Nanexa AB Elects Hanna Tilus as Members of the Board | CI |
May. 15 | Nanexa AB Receives Approval for NEX-22 Clinical Study | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
910.2 DKK | -0.60% | -1.55% | 592B | ||
1.07 SEK | -2.73% | +25.59% | 14.15M | ||
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.01% | 14.15M | |
-58.95% | 85.18M |
- Stock Market
- Equities
- NANEXA Stock
- News Nanexa AB
- Nanexa AB announced that it has received SEK 17.2 million in funding from Novo Nordisk A/S